Skip to main content

SMARCA4-deficient Malignant Tumors (With PI Approval) clinical trials at UC Cancer

1 research study open to eligible people

Showing trials for

Our lead scientists for SMARCA4-deficient Malignant Tumors (With PI Approval) research studies include .

Last updated: